The MarketReader Minute
VGT gained 0.7% since Friday, supported by optimism over potential Fed rate cuts and global growth signals. Broadcom surged on a major AI chip order from OpenAI, Oracle rose on analyst upgrades tied to AI infrastructure, while Adobe held ground despite a trimmed target.
The MarketReader Minute
IBB fell 0.7% since Friday on heavy trading volume, even as it remains up 8.25% YTD and posted a 3.55% weekly gain. Regeneron slipped despite positive Phase 3 antibody trial data, while Moderna and BioNTech declined on lung cancer trial updates.
The MarketReader Minute
U.S. Jobs Report Falls Short, Sparking Fed Rate Cut Speculation Amid Mixed Global Economic Signals and Political Turmoil in Japan.
The MarketReader Minute
(XLY) was flat on Thursday even as weak jobs data fueled rate cut expectations. Nonfarm payrolls rose by just 22,000, pushing unemployment to 4.3%. Lululemon tumbled after cutting sales guidance, yet XLY remains near 2025 highs alongside Communication Services.
The MarketReader Minute
(VGT) slipped 0.1% as nonfarm payrolls grew by just 22,000 in August, raising expectations of a Fed rate cut. Microsoft hit an eight-week low, Nvidia faced fresh AI competition, and Broadcom’s strong results were overshadowed by macro concerns, weighing on tech valuations.
The MarketReader Minute
U.S. Labor Market Slows with Only 22,000 Jobs Added in August; Germany's Factory Orders Drop 2.9%, Prompting Anticipation of Fed Rate Cuts.
The MarketReader Minute
U.S. Jobless Claims Surge to 237,000 Amid Layoffs; Asian Stocks Rise on Fed Dovishness as Eurozone Retail Sales Fall Sharply.
The MarketReader Minute
Global bond market sell-off drives investors to gold and the US dollar as concerns over fiscal sustainability rise, while U.S. mortgage applications decline amid weakening consumer confidence ahead of critical labor data release.
The MarketReader Minute
XLY underperformed alongside the S&P 500, with sharp losses in Nike and Carnival offset partly by strength in Ulta and Ralph Lauren. Amazon and Home Depot drew positive sentiment on Fed easing hopes, though concerns over Prime membership trends weighed on outlook.
The MarketReader Minute
IBB advanced with notable contributions from Cytokinetics, Ionis, and Biogen, supported by fresh approvals and positive clinical data. Eupraxia’s trial news added momentum, offsetting recent weekly weakness and lifting year-to-date gains to 4.6%.
The MarketReader Minute
US Dollar Index Rises Amid Global Bond Yield Surge and Inflation Concerns, Influencing Fed Policy Outlook.
The MarketReader Minute
U.S. Economic Data Shows Mixed Signals as Inflation Persists and Trade Deficit Widens, While European Fiscal Concerns Weigh on Market Sentiment Ahead of Key Fed Decisions.
